Swiss Life Asset Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.42M Buy
7,606
+498
+7% +$91.6K 0.01% 629
2026
Q1
$1.34M Buy
7,108
+1,029
+17% +$217K 0.01% 607
2025
Q4
$1.21M Buy
6,079
+1,774
+41% +$359K 0.01% 613
2025
Q3
$874K Buy
4,305
+1,856
+76% +$329K ﹤0.01% 637
2025
Q2
$431K Buy
+2,449
New +$369K ﹤0.01% 678
2016
Q2
Sell
-11,775
Closed -$341K 379
2016
Q1
$341K Buy
+11,775
New +$306K 0.01% 303

Other funds holding THC

Swiss Life Asset Management's THC Position: Q2 2026 in Review

Swiss Life Asset Management increased its Tenet Healthcare (THC) stake by 7% in Q2 2026, buying an estimated $91.6K and bringing the position to 7,606 shares worth $1.42M. The position accounts for 0.01% of the portfolio, ranked #629.

Swiss Life Asset Management first reported a position in THC in Q1 2016 and has held it in 6 quarters since. 440 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Swiss Life Asset Management held 7,606 shares of Tenet Healthcare worth $1.42M as of Q2 2026.
  • Swiss Life Asset Management bought 498 Tenet Healthcare shares in Q2 2026, an estimated $91.6K.
  • Tenet Healthcare made up 0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #629 holding.
  • Swiss Life Asset Management first reported a position in Tenet Healthcare in Q1 2016 and has held it in 6 quarters since.
  • 440 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.